The decision brings the first daily oral migraine prophylactic to Europe, with p...
Depending on Phase III results, survodutide could soon enter the weight loss mar...
Imugene's azercabtagene zarpreleucel (azer-cel) allo-CAR T cell therapy has show...
As restrictions on abortion drug mifepristone loom, doctors and patients are loo...
Coeptis Therapeutics has exclusively licensed allogeneic immuno-oncology platfor...
Bruker has entered into a definitive agreement to acquire functional cell biolog...
Competitive intelligence is a vital tool of the research and analysis toolbox fo...
What difference does a day make? How do you mail a gene therapy? And are biotech...
A feud has erupted between ViiV Healthcare and Doctors Without Borders over a de...
STAT spoke with Blue Shield of California’s chief operating officer about the co...
An international group of scientists argue that recent advances justify a new de...
A U.S. appeals court struck down key parts of an Oklahoma law designed to regula...
A U.S. appeals court panel restricted access to the abortion pill mifepristone b...
A South African court ruled the government must disclose contracts signed with p...
As drugmakers slowly wade into using digital health technologies in clinical tri...
By redesigning trial accommodations, eligibility criteria, and consent forms, we...
